Desensitization and belatacept-based maintenance therapy in pregnancy-sensitized monkeys receiving a kidney transplant
Science Advances · 2023
DOI: 10.1126/sciadv.adg1448 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Miriam Manook und 12 weiteren Autor:innen. Beteiligte Einrichtung: Duke Transplant Center, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA. Hauptthemen laut MEDLINE: Immunosuppressive Agents, Kidney Transplantation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Among sensitized patients awaiting a transplant, females are disproportionately represented, partly because of pregnancy-induced sensitization. Using female NHPs sensitized by pregnancy alone, we examined the efficacy of costimulation blockade and proteasome inhibition for desensitization. Three animals received no desensitization (control), and seven animals received weekly carfilzomib (27 mg/m 2 ) and belatacept (20 mg/kg) before kidney transplantation. All animals received renal allografts from crossmatch-positive/maximally MHC-mismatched donors. Controls and three desensitized animals received tacrolimus-based immunosuppression. Four desensitized animals received additional belatacept with tacrolimus-based immunosuppression. Multiparous females had less circulating donor-specific antibody when compared to skin-sensitized males before transplantation. While females receiving desensitization showed only a marginal survival benefit over control females (MST = 11 days versus 63 days), additional belatacept to posttransplant maintenance significantly prolonged graft survival (MST > 164 days) and suppressed posttransplant DSA and circulating follicular helper T-like cells. This combination of therapies demonstrates great potential to reduce antibody-mediated rejection in sensitized recipients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Duke Transplant Center, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
- Department of Pathology, Emory University School of Medicine, Atlanta, GA, USA.
ORCID-Profile: Miriam Manook, Danae Olaso, Imran J Anwar, Janghoon Yoon, Isabel Delaura, Yeeun Bae, Brian Shaw, Alton B Farris, Annette Jackson, Jean Kwun, Stuart Knechtle
Förderung
- NIAID NIH HHS
Zitieren
APA
Manook, M., Olaso, D., Anwar, I. J., Yoon, J., Delaura, I., Bae, Y., Moris, D., Shaw, B., Song, M., Farris, A. B., Jackson, A., Kwun, J., & Knechtle, S. (2023). Desensitization and belatacept-based maintenance therapy in pregnancy-sensitized monkeys receiving a kidney transplant. Science Advances. https://doi.org/10.1126/sciadv.adg1448
Vancouver
Manook M, Olaso D, Anwar IJ, Yoon J, Delaura I, Bae Y, et al. Desensitization and belatacept-based maintenance therapy in pregnancy-sensitized monkeys receiving a kidney transplant. Science Advances. 2023. doi:10.1126/sciadv.adg1448
BibTeX
@article{Manook2023,
author = {Manook, Miriam and Olaso, Danae and Anwar, Imran J and Yoon, Janghoon and Delaura, Isabel and Bae, Yeeun and Moris, Dimitrios and Shaw, Brian and Song, Mingqing and Farris, Alton B and Jackson, Annette and Kwun, Jean and Knechtle, Stuart},
title = {Desensitization and belatacept-based maintenance therapy in pregnancy-sensitized monkeys receiving a kidney transplant},
journal = {Science Advances},
year = {2023},
doi = {10.1126/sciadv.adg1448}
}
EUVIMED